Poly Medicure Limited has informed the Exchange about Investor s Presentation on Acquisition of Pendracare Group (a unique interventional cardiology consumable asset in Europe.

Listed-company acquisitionStrategic Transactions View source PDF Explain this filing

POLYMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.2%Reaction day

₹2064.10

prior close

₹2109.90

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.7%-0.5% vs market

Medical Equipment & Supplies peers, median of 11sector+1.0%-2.2% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Smallcap 250 and 2.2 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.2

10m

-1.3

15m

-1.3

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.2-0.7-0.5+1.0-2.2

Next day

-1.2-0.4-0.7+1.1-2.3

-2.3-0.3-2.0+0.1-2.4

-3.1+0.0-3.1-0.5-2.6

-4.6+0.7-5.2+0.7-5.3

-3.1+0.7-3.7-0.2-2.9

-3.7+1.6-5.4-1.5-2.2

15d

-1.7+0.4-2.1-4.0+2.3

-8.2+0.3-8.5-4.3-3.9

-5.3+2.0-7.3-4.4-0.9

-7.4-2.3-5.1-12.2+4.7

UpDownMarket · Nifty Smallcap 250Sector · Medical Equipment & Supplies peers, median of 11Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Poly Medicure Limited has informed the exchange about an investor presentation covering its acquisition of Pendracare Group. Pendracare is described as a unique interventional cardiology consumable asset based in Europe. The filing shares the presentation with investors to explain the strategic rationale and details of the deal. This acquisition strengthens Poly Medicure's footprint in the cardiology consumables segment and expands its presence in the European market.

Likely market impact

This acquisition signals international expansion into a specialised cardiology segment, which could boost long-term revenue and product portfolio. Short-term stock movement may depend on deal valuation and integration outlook shared in the presentation.